Literature DB >> 3469226

The capability of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius to indicate progressive periodontitis; a retrospective study.

L Bragd, G Dahlén, M Wikström, J Slots.   

Abstract

This study evaluated the statistical association of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius with progressive periodontitis. 146 adults with a history of advanced periodontitis contributed 105 "nonprogressing" and 130 "progressing" periodontal sites. Periodontal disease activity was assessed by radiographic changes in crestal alveolar bone level. The subgingival proportion of the 3 test bacteria was determined by selective and nonselective culturing. The relationship between bacterial proportions and disease progression was evaluated using subgrouping and multiple-regression analyses. All 3 test bacteria had to be considered in order to distinguish nonprogressing and progressing periodontitis with a reasonably high sensitivity. A recovery rate below 0.01% for A. actinomycetemcomitans, 0.1% for B. gingivalis and 2.5% for B. intermedius defined a site with nonprogressing disease with 87% sensitivity and 84% specificity. By utilizing transformed values of the bacterial recovery rates and optimal test criteria determined by multiple regression analysis, it was possible to obtain sensitivities between 83% and 95% and specificities between 86% and 69%. These 3 bacterial species might serve as valuable components of a periodontitis activity test based on microbiological variables.

Entities:  

Mesh:

Year:  1987        PMID: 3469226     DOI: 10.1111/j.1600-051x.1987.tb00949.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  22 in total

1.  Gingival fluid ciprofloxacin levels at healthy and inflamed human periodontal sites.

Authors:  T B Conway; F M Beck; J D Walters
Journal:  J Periodontol       Date:  2000-09       Impact factor: 6.993

2.  T-cell expression cloning of Porphyromonas gingivalis genes coding for T helper-biased immune responses during infection.

Authors:  Reginaldo B Gonçalves; Onir Leshem; Karen Bernards; John R Webb; Philip P Stashenko; Antonio Campos-Neto
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  Th1 immune response promotes severe bone resorption caused by Porphyromonas gingivalis.

Authors:  Philip Stashenko; Reginaldo B Gonçalves; Brad Lipkin; Alexander Ficarelli; Hajime Sasaki; Antonio Campos-Neto
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

4.  Periodontal disease in chronic kidney disease and end-stage renal disease patients: a review.

Authors:  Venkatesh K Ariyamuthu; Karl D Nolph; Bruce E Ringdahl
Journal:  Cardiorenal Med       Date:  2013-04       Impact factor: 2.041

5.  The role of Actinobacillus actinomycetemcomitans in periodontal disease.

Authors:  J de Graaff; A J van Winkelhoff; R J Goené
Journal:  Infection       Date:  1989 Jul-Aug       Impact factor: 3.553

6.  Identification of Actinobacillus actinomycetemcomitans in subgingival plaque by PCR.

Authors:  T F Flemmig; S Rüdiger; U Hofmann; H Schmidt; B Plaschke; A Strätz; B Klaiber; H Karch
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

Review 7.  Should Antibiotics Be Prescribed to Treat Chronic Periodontitis?

Authors:  John Walters; Pin-Chuang Lai
Journal:  Dent Clin North Am       Date:  2015-08-01

8.  Effects of anaerobiosis and aerobiosis on interactions of human polymorphonuclear leukocytes with the dental plaque bacteria Streptococcus mutans, Capnocytophaga ochracea, and Bacteroides gingivalis.

Authors:  H L Thompson; J M Wilton
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

9.  Analysis of neutrophil-derived antimicrobial peptides in gingival crevicular fluid suggests importance of cathelicidin LL-37 in the innate immune response against periodontogenic bacteria.

Authors:  M Puklo; A Guentsch; P S Hiemstra; S Eick; J Potempa
Journal:  Oral Microbiol Immunol       Date:  2008-08

10.  Killing of Actinobacillus actinomycetemcomitans by human lactoferrin.

Authors:  J R Kalmar; R R Arnold
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.